Improving Intermediate Lactate Sepsis Bundle Performance by Alimboyoguen, Jocelyn
The University of San Francisco
USF Scholarship: a digital repository @ Gleeson Library |
Geschke Center
Master's Projects and Capstones Theses, Dissertations, Capstones and Projects
Summer 8-7-2018
Improving Intermediate Lactate Sepsis Bundle
Performance
Jocelyn Alimboyoguen
jocelyn.a@comcast.net
Follow this and additional works at: https://repository.usfca.edu/capstone
Part of the Nursing Commons
This Project/Capstone is brought to you for free and open access by the Theses, Dissertations, Capstones and Projects at USF Scholarship: a digital
repository @ Gleeson Library | Geschke Center. It has been accepted for inclusion in Master's Projects and Capstones by an authorized administrator
of USF Scholarship: a digital repository @ Gleeson Library | Geschke Center. For more information, please contact repository@usfca.edu.
Recommended Citation
Alimboyoguen, Jocelyn, "Improving Intermediate Lactate Sepsis Bundle Performance" (2018). Master's Projects and Capstones. 799.
https://repository.usfca.edu/capstone/799
Improving Intermediate Lactate     1 
Running head: IMPROVING INTERMEDIATE LACTATE SEPSIS BUNDLE 
 
 
 
 
 
 
 
 
Improving Intermediate Lactate Sepsis Bundle Performance 
Jocelyn Alimboyoguen 
University of San Francisco 
 
 
 
 
Improving Intermediate Lactate     2 
Improving Intermediate Lactate Sepsis Bundle Performance 
Abstract 
The aim of this project is to improve intermediate sepsis bundle performance with a 
primary focus on repeat lactate within 6 hours of arrival in the ED.  One of the most significant 
problems we are facing today in healthcare, with an incidence of 300 to more than 1,000 cases 
per 100,000 persons annually in the United States, is severe sepsis (Gaieski, Edwards, Kalian, & 
Carr, 2013).  Multiple studies have shown a strong correlation in reducing hospital and 30-day 
mortality by implementing process-oriented bundle for patients with sepsis and intermediate 
lactate values in accordance with the Surviving Sepsis Campaign guidelines.  The site for this 
quality improvement project is a not-for-profit, medium-sized, tertiary hospital serving the San 
Joaquin and Stanislaus county communities.  The improvement team comprised of a CNL 
student, physician champions, unit nurse champions, educators, and staff champions from lab, 
radiology, and pharmacy.  The interventions for this project include, (a) developing a sepsis 
screening tool to help frontline nurses recognize early signs of sepsis, (b) developing a 
standardized process between lab and nursing for repeat lactate orders, (c) implementing the 
sepsis clockvs tool which outlines timely appropriate treatment based on clinical guidelines for 
patients diagnosed with sepsis, and (d) implement a sepsis alert protocol to activate early and 
appropriate interventions.  Results show that use of a screening tool to help identify early signs 
of sepsis as well as use of sepsis clock tool which serves as a visual aid for the staff to keep track 
of specific timelines increased compliance with the sepsis bundle.   
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Introduction 
Healthcare delivery in the 21st century continues to evolve to provide world-class quality 
of care in order to produce optimal patient outcomes. As care delivery shifts within a 
department’s mission to best accommodate and meet the needs of the patient population, it is 
imperative for department members to feel empowered in their role as an integral part of the 
healthcare delivery team. With the shift in focus from volume to value-based care, much 
emphasis is placed on performance improvement, identifying best practices, and transforming 
healthcare delivery (Zangerle, Harris, Rimmasch, & Randazzo, 2016). 
One of the most significant problems we are facing today in healthcare, with an incidence 
of 300 to more than 1,000 cases per 100,000 persons annually in the United States, is severe 
sepsis (Gaieski, Edwards, Kalian, & Carr, 2013).  The number of critically ill patients presenting 
in the ED with sepsis is staggering.  According to Hall et al. (2011), the number of patients in the 
hospital with a principal diagnosis of sepsis or septicemia has more than doubled from 11.6 in 
2000 to 24.0 in 2008 per 10,000 patients with mortality associated with severe sepsis ranging at 
30% - 60% (Hall, Williams, DeFrances, & Golosinskiy, 2011).  Guidelines for early 
identification and treatment of sepsis has been known to decrease sepsis mortality by at least 
14% or 12,500 lives saved per year (Moore et al., 2009).  In addition, multiple studies have 
shown a strong correlation in reducing hospital and 30-day mortality by implementing process-
oriented bundle for patients with sepsis and intermediate lactate values in accordance with the 
Surviving Sepsis Campaign guidelines.  However, although these bundles are associated with 
improved patient outcomes, adherence to these bundles remain to be an area of opportunity 
(Ramsdell, Smith, and Kerkhove, 2017). 
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Therefore, this project aims to improve intermediate sepsis bundle performance with a 
primary focus on repeat lactate within 6 hours of arrival in the ED.  The sepsis bundle is 
comprised of early recognition and treatment of sepsis which includes: Lactate drawn within one 
hr. of ED arrival, appropriate antibiotic administered within 3 hrs. of ED arrival, fluids 
administered appropriately within 3 hrs. of ED arrival, and repeat lactate drawn within 6 hrs. of 
ED arrival.  Harris, Roussell, and Thomas (2014) states that the microsystem is a setting in 
which collaborative members of teams have the opportunity to test changes in healthcare 
delivery that directly impact patient outcomes.  Therefore, this project aims to improve 
intermediate sepsis bundle compliance in the ED, thereby reducing sepsis mortality.     
Problem Description 
The site for this quality improvement project is a not-for-profit, tertiary hospital serving 
the San Joaquin and Stanislaus county communities.  This medium-sized community hospital is 
licensed to operate 152 beds and offers many different services ranging from 24/7 emergency 
room, intensive care, medical/surgical/telemetry as well as maternity and pediatrics. The 
hospital’s mission is “to provide high quality, affordable health care services and improve the 
health of our members and the communities we serve.”  Sepsis is the number one top diagnosis 
followed by CHF, Major surgery, GI bleed, Stroke, Cancer, Pancreatitis, ESRD, Diabetes, and 
Cellulitis.  Thirty-nine percent of patients are discharged to home and 36% are discharged to a 
skilled nursing facility.  The microsystem observed for this study is the ED.    
Due to the wide array of diagnoses that this microsystem is often subjected to, teamwork 
and collaboration are of up-most importance among the staff members. Therefore, a 
multidisciplinary approach is necessary for providing high-quality patient care.  Some potential 
barriers to change include staff resistance, staff shortage, resources, and trust which can often 
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evoke feelings of frustration. Therefore, utilizing the CNL’s skill to build trust, to empower and 
influence teamwork is a critical piece in bringing about change.  Finkelman (2016) recognized 
transformational leadership as one of the most effective styles of leadership in our healthcare 
system today.  A transformational leader not only rewards but also provides guidance to help 
staff work towards a common or shared vision that embraces change and fosters positive work 
environments.  Based on a review of the data for this microsystem, the sepsis intermediate lactate 
bundle performance has been well below the target of 55% for at least 9 out of the past 12 
months.  The “All or None” bundle is comprised of a minimum of 3 to a maximum of 7 
elements.  The performance was at times 35 percentage points lower than target.  As a result, this 
medical center is one of the lowest performers in the region, which warrants a quality 
improvement project in order to improve performance with a primary focus on repeat lactate. 
Available Knowledge 
PICOT Question: Intermediate sepsis bundle 
The PICOT question that guided the search for evidence in this project was: For patients 
identified with severe sepsis in the ED (P), does increasing compliance with intermediate sepsis 
bundle (I) compared to non-adherence to the bundle (C) improve sepsis care and reduce 
mortality outcome (O) from January 2018 to July 2018 (T).  
Literature Review 
A comprehensive electronic search was conducted in September 2017 reviewing 
evidence that examined sepsis management and its impact on patient outcomes in the following 
databases: Cochrane Database of Systemic Reviews, CINAHL Complete, and Pub Med. These 
databases were searched using combinations of the following search terms: severe sepsis, sepsis 
bundle, guidelines, sepsis screening. Limitations were set to include English only, peer-reviewed, 
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research, systemic reviews, randomized controlled trials, and publication dates no earlier than 
2009. The search yielded 63 articles. Articles were considered for inclusion if they included 
severe sepsis and early identification/screening.  Five articles specific to sepsis were selected for 
review.  The Research Evidence Appraisal Tool (Dang & Dearholt, 2017) was used to appraise 
the evidence for this review. The appraisal tool (See Appendix G) includes criteria to evaluate 
the strength and quality of the evidence.  The articles were appraised to be a Level 5 due to the 
fact that this is a quality improvement project.  One article rated as high quality while the other 
four articles rated as good quality.  These articles were very useful as it provided the evidence 
needed for this quality improvement project.   
According to Mitchell (2013), cultural change occurs when new methods produce 
desirable behavioral change and superior performance.  As previously mentioned, guidelines for 
early identification and treatment of sepsis has been known to decrease sepsis mortality by at 
least 14% or 12,500 lives saved per year (Moore, Jones, Kreiner, McKinley, Sucher, Todd, 
Turner, Valdivia, and Moore, 2009).  Evidence-based practice (See Appendix B) has shown that 
interventions such as the sepsis intermediate lactate bundle has proven to be an effective 
treatment.   
Rationale 
While there are multiple methods of facilitating change at the organizational level, the 
assistance of a change agent is necessary to assure that all efforts are purposeful, calculated, and 
collaborative (Mitchell, 2013).  According to Mitchell (2013), choosing a change theory for 
change agents to use that will provide a framework for implementing, managing and evaluating 
change is critical.  Kotter’s 8-step Process for leading change provides an effective framework 
for implementing the CNL’s change strategy.  This eight-step process includes “establishing a 
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sense of urgency, creating the guiding coalition, developing a vision and strategy, 
communicating the change vision, empowering broad-based action, generating short-term wins, 
consolidating gains and producing more change, and anchoring new approaches in the culture” 
(Kotter, 1996). 
Kotter’s eight-step process for change will be applied in the planning, development, 
implementation and evaluation phases of this change strategy project.  Like most EDs, this is a 
fast-paced microsystem where changes occur constantly.  Providing patient-centered care amid 
constant change can be challenging and stressful at times. Therefore, even though the nurses are 
accustomed to frequent change, it is imperative that process changes be implemented in a way 
that is sensitive to the level of stress the nurses are experiencing.  Also, it needs to be organized 
in a way that will cause the least disruption in their ability to provide safe patient care.  With this 
in mind, Kotter’s eight-step process will guide the action plan for the implementation of this 
change strategy and provide a systematic approach that will guide the primary change agent 
through a series of actions that can lead to enhanced change outcomes.  In addition, the model 
for improvement framework will be used to test change ideas and determine if the change is an 
improvement using the Plan-Do-Study-Act (PDSA) method (See Appendix L).   
Specific Project Aim 
To increase the percentage of patients with a documented elevated intermediate lactate 
who receive intermediate lactate bundle interventions, from a baseline of 43% per month to 55% 
per month by July 2018 with a primary focus on repeat lactate within 6 hours.   
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Context 
Microsystem Assessment 
Understanding the microsystem is an important step toward improvement and provides 
the opportunity to transform the delivery of care at the front line (Nelson, Batalden & Godfrey, 
2007, p.6). Using the Dartmouth assessment tool provided a systematic and objective review of 
the microsystem which focused on the 5 P’s: purpose, patients, professionals, processes, and 
patterns.  This tool helped gain a better understanding of the microsystem and provided baseline 
information necessary to build a successful high functioning microsystem which is the building 
block of all health care systems (Nelson, Batalden & Godfrey, 2007).  The purpose of this 
hospital revolves around “improving the health of our members and the communities we serve”.  
The team works passionately to fulfill this promise by establishing processes that ensurepatient 
safety and effective clinical care.  They strive to deliver excellent care by reducing mortality, 
length of stay, and complications through a multidisciplinary approach.  The team believes that 
collaboration with key stakeholders is a key component to success.  There is significant number 
of the Patient population seen and assessed that are from low-income communities.  There has 
been an increase in the number of patients served at this hospital who are uninsured and rely on 
Medi-Cal for coverage of treatment and services. The professional team is comprised of, but not 
limited to, ER physicians, an HBS physician, registered nurses, physician assistants, and other 
ancillary staff.  Supporting diagnostic departments are available as needed.  Thirty-three percent 
of the staff state that working in the unit is stressful.  However, 76% of the staff state that they 
would recommend their unit as a good place to work.  The processes of patient care are focused 
on patient stabilization and personalized treatment to fit every individual’s plan of care. The unit 
has processes in place to ensure patient safety and excellent transition of care.  In addition, the 
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unit has a very engaged rapid response team and multidisciplinary team that rounds on patients 
to discuss patient progress and discharge goals.  The pattern consists of a multidisciplinary team- 
based approach to provide high-quality care that prioritized patient safety and satisfaction. There 
is a monthly nurse quality forum in which representatives of the team participate in to discuss 
clinical care issues.  Also, there is a workgroup that meets monthly to discuss patient safety 
issues or concerns.  The unit team takes pride in involving the patients and family members in 
their care.  The team has gone through some challenges in the last year and a half with leadership 
turnovers and staff shortage which has dampenend the morale of the team.  However, they are 
encouraged and optimistic about their new leadership and onboarding of new staff. 
The SWOT analysis (See Appendix K) revealed that the strengths of this project included 
improved patient outcome and standardization. The team’s commitment to provide exceptional 
quality care and their openness to evidence-based practices that improve patient care are also 
their strengths.  An identified weakness is that, although there is a sepsis workgroup already in 
existence, it was not effective.  In addition, although the severe sepsis protocol has been 
standardized, the nurses and providers still did not follow the process as outlined within the 
bundle. There was also variation in the approach to sepsis identification and treatment which was 
identified as an opportunity.  Threats include insufficient education/training due to lack or 
resources and time.  Also, the potential for lack of interest and inconsistency by providers was 
identified as a threat.  This analysis was shared with the team during the kick-off meeting. 
Based on data compiled on the number of sepsis alerts per month for this medical center, 
the emergency department sees approximately 40-43 sepsis patients per month which equals to 
about 1.3 to 1.4 patients a day.  This equates to about 480 – 516 patients being treated each year 
for sepsis at this facility and roughly estimates to 8.6 - 9.3 million dollars in sepsis treatment a 
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year.  By increasing compliance to the intermediate lactate bundle ensuring that the patient 
receives the appropriate treatment according to the protocol, then the possibility of reducing the 
average LOS by 3.2 days in the ICU alone can save the organization a staggering $1.7 million 
per year (See Appendix F). 
Intervention 
To provide the best possible patient-centered care maximizing the overall health of our 
members we needed to provide sepsis intermediate lactate bundle re-education for physicians, 
nurses, lab and pharmacy personnel.  In addition, evidence supported early identification of signs 
and symptoms of severe sepsis by frontline nurses using a sepsis screening tool (Moore, Jones, 
Kreiner, McKinley, Sucher, Todd, Turner, Valdivia, and Moore, 2009).   
Changes that were implemented include: (1) a revised sepsis screening tool to help 
frontline nurses recognize early signs of sepsis, (2) a sepsis alert protocol via an overhead page 
to activate early and appropriate interventions, (3) a revised sepsis reminder time tool which 
outlined timely appropriate treatment based on clinical guidelines for patients diagnosed with 
sepsis, and (4) a standardized process between lab and nursing for repeat lactate orders.  Data 
collecting methods include chart reviews, observations, and the use of a survey to determine 
compliance with use of the tools and processes as outlined.  
Study of the Intervention 
 Evidence-based practice has shown that interventions such as the sepsis intermediate 
lactate bundle have proven to be an effective treatment.  Aiming for increased compliance in 
following the sepsis bundle will result in reduced mortality, reduced readmission, reduced length 
of stay, and reduced complications from sepsis, i.e. renal failure. 
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 Data was obtained from 100% retrospective medical record review of the patient records 
for project measures per week from January – April 2018.  Concurrent observations were 
conducted when a sepsis alert was called to see if the sepsis screening tool was used for 
identification of early signs of sepsis.  In addition, an audit of the use of the sepsis reminder time 
tool was performed each time a sepsis alert was called.  Weekly email communication was sent 
out to update the team on their progress.  The PDSA cycle (See Appendix L) results were 
evaluated every month at the sepsis workgroup meeting.  Cycle 1 took a couple of weeks to 
implement because we had to ensure that the sepsis alert was not only announced overhead but 
that it also generated an automated message that was sent via text to designated team members 
on their mobile phones as well as an automated call on their office work phones.  These calls 
made it very easy for staff to spring into action once they were notified or heard the sepsis alert.  
Cycle 2 also took a couple of weeks because the staff determined that they needed to revise the 
sepsis screening tool so that it was easier for all the staff to use.  This was a very important step 
since it was the team’s idea to revise the tool, it made it easier to get buy-in from all the staff.  
The team had to go through the same process for the sepsis clock.  The staff agreed that they 
would rename it as a sepsis reminder time tool.  Once both tools were revised and 
implementation of the tools went very smoothly.   
Measures 
 
This project included an outcome measure which was to increase intermediate lactate  
bundle compliance.  Within this bundle, there are four process measures which include lactate 
drawn within one hour of ED arrival, appropriate antibiotic administered within three hours of 
ED arrival, fluids administered appropriately within three hours of ED arrival, and repeat lactate 
drawn within six hours of ED arrival.   Of these four elements, the one that this unit struggled 
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the most with was the repeat lactate drawn within six hours of ED arrival.  Therefore, the team 
agreed that they would focus on this process measure as part of this improvement project.  
Lastly, as a balancing measure, the team agreed to monitor if there would be an increase in 
workload for laboratory staff causing delay in completing other lab orders as a result of this 
project.  Performance on these measures will be monitored with data displayed over time using 
Statit graphs.  Please see Appendix C for family of measures and measure definition.  
Ethical Considerations 
 
As an advocate, the CNL role provides an opportunity to address the concerns of 
colleagues, providing a platform for discussion, providing opportunities to reinforce the 
positives.  Ethical considerations were taken to ensure that there was no unfair discrimination 
based on age, gender, gender identity, race, ethnicity, culture, national origin, religion, sexual 
orientation, disability, socioeconomic status, or any basis proscribed by law.  In addition, steps 
were taken to ensure there was no financial conflict of interest.  The project was reviewed by 
faculty and is determined to qualify as an Evidence-based Change in Practice Project, rather than 
a Research Project.  Institutional Review Board (IRB) review is not required (See Appendix A, 
IRB Non-Research Determination Form).  Lastly, Privacy and Confidentiality were taken into 
consideration to build trust, to empower and influence teamwork, which is a critical piece in 
bringing about change. 
Results 
Following initiation of the sepsis alert via overhead page in January, results show that 
there was a total of 165 sepsis alerts called between January to April 2018.  An audit of these 
cases revealed that utilization of the sepsis screening tool and the sepsis time reminder tool 
ranged from 65% to 90% (See Appendix J).  In addition, results show that compliance with the 
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use of the sepsis screening tool (See Appendix H) and sepsis time reminder tool (See Appendix 
I) resulted in improved intermediate sepsis bundle performance starting in January (See 
Appendix D).  Performance in February continued to show improvement which was above the 
target of 55%.  Lastly, repeat lactate compliance also showed significant improvement after 
standardizing a workflow process between lab and nursing for repeat lactate orders (See 
Appendix F).  This data suggests that consistent use of the sepsis screening tool and the sepsis 
reminder time tool resulted in increased performance with the intermediate lactate bundle 
compliance which evidence also suggest.  Secondarily, there seems to be a correlation with the 
improved repeat lactate performance and the improved intermediate lactate bundle performance 
as shown in the graph. 
Discussion 
Summary 
According to Mitchell (2013), cultural change occurs when new methods produce 
desirable behavioral change and superior performance.  The improvement in performance as 
shown in Appendix D and Appendix F had it not been for the cultural shift within this unit.  It 
was not until the staff recognized the need for change and took ownership of the change process 
that improvement occurred.  The staff took the initiative to take the tools that were not working 
for them and changed it so that they had a tool that was easier for the staff to use and developed 
a process that was sustainable and not person dependent.  Also, having the sepsis physician and 
nurse champions who drove the process improvement efforts made a significant difference.  So 
far, current performance has been above target for the last 3 months which shows that the 
interventions worked.  As mentioned earlier, results from this project has the potential of 
reducing the average LOS by 3.2 days for patients admitted in the ICU.  This can potentially 
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save the organization $1.7 million per year.  In addition to the cost-saving factor for this 
improvement project, an increase in patient satisfaction may also be obtained since patients are 
able to go home sooner rather than later.  Although this is only a soft dollar benefit, providing 
the patient an excellent care experience is rewarding in and of itself.  Ultimately, I believe this is 
the greatest incentive for conducting a performance improvement project.   
Conclusion 
As mentioned earlier, the focus of this project is to improve intermediate lactate bundle 
performance by providing tools to help nurses identify sepsis early and allowing treatment to be 
started timely to achieve a better outcome for the patient.  The CNL role is in a unique position 
to reinforce change, and has been historically proven effective in facilitating changes in the 
microsystem level, having a positive impact on patient outcomes (Stanley et al., 2008).  Also, the 
CNL functions as a quality manager who is skillful at identifying departmental needs and 
championing cost-effective, evidence-based care within the microsystem which is vital to this 
improvement project.  While there were some delays in getting the project going, overall, 
implementation of the sepsis screening tool and the sepsis reminder time tool and re-educating 
the staff regarding the hospital’s sepsis protocol went very smoothly.  The aim of the project was 
achieved within the second month of implementation.   
Emphasizing staff empowerment not only helped implement the change but it also helped 
improve the unit environment.  Utilizing sepsis nurse and physician champions to hardwire the 
process was a critical factor for this project along with a cultural shift which resulted in increased 
compliance to the intermediate lactate bundle and provided a strong possibility for sustainability. 
In conclusion, I feel that this change strategy positively impacted the lives of our patients as well 
as the overall health of the organization.  
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Appendix A 
CNL Project: Statement of Non-Research Determination Form                                                                                                             
Title of Project:  
Improving Sepsis Care by improving intermediate lactate bundle performance 
Brief Description of Project:  
One of the most significant problems we are facing today in healthcare, with an incidence of 
300 to more than 1,000 cases per 100,000 persons annually in the United States, is severe 
sepsis (Gaieski, Edwards, Kalian, & Carr, 2013). The number of critically ill patients 
presenting in the ED with sepsis is staggering.  According to Hall et al. (2011), the number 
of patients in the hospital with a principal diagnosis of sepsis or septicemia has more than 
doubled from 11.6 in 2000 to 24.0 in 2008 per 10,000 patients with mortality associated with 
severe sepsis ranging at 30% - 60% (Hall, Williams, DeFrances, & Golosinskiy, 2011). 
Guidelines for early identification and treatment of sepsis has been known to decrease sepsis 
mortality by at least 14% or 12,500 lives saved per year (Moore, Jones, Kreiner, McKinley, 
Sucher, Todd, Turner, Valdivia, and Moore, 2009).   
A) Aim Statement:  
To improve sepsis care by increasing compliance with the intermediate lactate bundle from 
43% to 55% by July 2018.   
B) Description of Intervention:  
To provide the best possible patient-centered care maximizing the overall health of our 
members, we need to provide Sepsis intermediate lactate bundle re-education for physicians, 
nurses, lab and pharmacy personnel.  In addition, evidence supports early identification of 
signs and symptoms of severe sepsis by frontline nurses using a sepsis screening tool. 
C) How will this intervention change practice?  
Evidence based practice has shown that interventions such as the sepsis intermediate lactate 
bundle has proven to be an effective treatment.  Aiming for increased compliance in 
following the sepsis bundle elements will result in reduced mortality, reduced readmission, 
reduced length of stay, and reduced complications from sepsis. 
 
D) Outcome measurements:  
Outcome:  Increased Sepsis Bundle compliance for Intermediate lactate 
Process:     Repeat Lactate Drawn within 6 hrs. of ED arrival 
Balancing: Increase in workload for lab staff causing delay in completing other lab orders 
 
 
To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the 
criteria outlined in federal guidelines will be used: (http://answers.hhs.gov/ohrp/categories/1569)  
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× This project meets the guidelines for an Evidence-based Change in Practice Project as outlined 
in the Project Checklist (attached). Student may proceed with implementation. 
☐This project involves research with human subjects and must be submitted for IRB approval 
before project activity can commence. 
Comments:   
EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST * 
Instructions: Answer YES or NO to each of the following statements: 
Project Title: Improving Intermediate Lactate Sepsis Bundle Performance  
 
YES NO 
The aim of the project is to improve the process or delivery of care with 
established/ accepted standards, or to implement evidence-based change. There 
is no intention of using the data for research purposes. 
X  
The specific aim is to improve performance on a specific service or program and 
is a part of usual care.  ALL participants will receive standard of care. 
X  
The project is NOT designed to follow a research design, e.g., hypothesis testing 
or group comparison, randomization, control groups, prospective comparison 
groups, cross-sectional, case control). The project does NOT follow a protocol 
that overrides clinical decision-making. 
X  
The project involves implementation of established and tested quality standards 
and/or systematic monitoring, assessment or evaluation of the organization to 
ensure that existing quality standards are being met. The project does NOT 
develop paradigms or untested methods or new untested standards. 
X  
The project involves implementation of care practices and interventions that 
are consensus-based or evidence-based. The project does NOT seek to test an 
intervention that is beyond current science and experience. 
X  
The project is conducted by staff where the project will take place and involves 
staff who are working at an agency that has an agreement with USF SONHP. 
X  
The project has NO funding from federal agencies or research-focused 
organizations and is not receiving funding for implementation research. 
X  
The agency or clinical practice unit agrees that this is a project that will be 
implemented to improve the process or delivery of care, i.e., not a personal 
research project that is dependent upon the voluntary participation of 
colleagues, students and/ or patients. 
X  
If there is an intent to, or possibility of publishing your work, you and 
supervising faculty and the agency oversight committee are comfortable with 
the following statement in your methods section: “This project was undertaken 
as an Evidence-based change of practice project at X hospital or agency and as 
such was not formally supervised by the Institutional Review Board.”  
X  
*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human 
Research Committee, Partners Health System, Boston, MA.   
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Appendix B 
Evaluation Table 
Study Design Sample Outcome/Feasibility Evidence rating  
Amland, R. C., & Hahn-
Cover, K. E. (2016). Clinical 
Decision Support for Early 
Recognition of Sepsis. 
American Journal of Medical 
Quality, 31(2), 103–110.  
Quality 
Improvement 
using 
retrospective 
cohort design 
 
817 Patients 
were segmented 
into one of 3 
cohorts based on 
intervals 
between first 
alert activation 
and initial orders 
for diagnostics 
and 
interventions. 
Provides guidelines 
for cloud-based 
sepsis CDS. 
Integrated with 
enterprise EHR 
systems can be an 
effective approach 
toward early 
recognition of sepsis 
in a hospital setting. 
L V A 
Clinical Decision 
Support for Early Re    
Drahnak, D. M. (2016). 
Scripting Nurse 
Communication to Improve 
Sepsis Care. 
Quality 
Improvement 
project using 
pre- & post- 
survey design 
Conducted in a 
648-bed Level 1 
trauma hospital 
using a 
randomized 
sample involving 
681 nurses. 
Provides a strong 
foundation on which 
to build an inter-
professional 
organizational sepsis 
treatment program. 
L V B 
Nurse 
communication to im   
Gaieski, D., Edwards, J., 
Kallan, M., Carr, B. 
Benchmarking the incidence 
and mortality of severe sepsis 
in the United States. Crit Care 
Med. 2013;41(5):1167-1174. 
 
Case 
presentation   
none A uniform, 
consistent method is 
needed for use in 
national registries to 
facilitate accurate 
assessment of 
clinical interventions 
and outcome 
comparisons between 
hospitals and 
regions. 
L V B 
Benchmarking the 
Incidence and Morta     
Moore, L., Jones, S., Kreiner, 
L., McKinley, B., Sucher, J., 
Todd, S., Turner, K., Valdivia, 
A., Moore, F. (2009). 
Validation of a sepsis 
screening tool for the early 
identification of sepsis. The 
Journal of Trauma, Infection, 
and Critical Care, 66(6), 1539-
1547 
Quality 
Improvement 
retrospective 
observational 
design 
 
Conducted 4,991 
sepsis screens on 
920 patients 
representing 927 
ICU admissions. 
Implementation of 
this tool and logic-
based sepsis protocol 
has decreased sepsis-
related mortality. 
L V B 
Validation of a 
Screening Tool for E     
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Stanley, J. M., Gannon, J., 
Gabuat, J., Hartranft, S., 
Adams, N., Mayes, C., & 
Burch, D. (2008). The clinical 
nurse leader: A catalyst for 
improving quality and patient 
safety. Journal of Nursing 
Management, (5), 614. 
Case 
presentation 
None Through formal, 
standardized 
education programs, 
and nationally 
recognized role 
competencies and 
expectations, the 
CNL represents a 
promising 
opportunity for 
nursing to take a 
leadership role in 
implementing quality 
improvement and 
patient safety 
initiatives across all 
health care settings. 
L V A 
The Clinical Nurse 
leader. a catalyst for   
Ramsdell, T.H., Smith, A.N., 
and Kerkhove, E. (2017). 
Compliance with Updated 
Sepsis Bundles to Meet New 
Sepsis Core Measure in a 
Tertiary Care Hospital 
Quality 
Improvement 
retrospective 
cohort design 
 
Conducted in 
158 patients with 
a diagnosis of 
severe sepsis or 
septic shock 
from April 2015 
to February 
2016. 
Increased adherence 
to the care bundles 
may improve in-
hospital survival. 
Implementation of 
BPA messages 
allows for rapid 
identification of 
sepsis and provides 
for immediate access 
to checklists and 
order sets for timely 
initiation of 
appropriate 
treatment. 
L V B 
Compliance with 
Updated Sepsis Bun        
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Appendix C 
Project Charter 
Project Charter:  
Improving Sepsis Care by improving intermediate lactate bundle performance. 
 
Global Aim:  
To reduce Severe Sepsis (lactate 2-4) mortality from 7.8% to 5.3%. 
 
Specific Aim:  
To improve sepsis care by increasing compliance with the intermediate lactate bundle from 43% 
to 55% by July 2018.   
Background:  
One of the most significant problems we are facing today in healthcare, with an incidence of 300 
to more than 1,000 cases per 100,000 persons annually in the United States, is severe sepsis 
(Gaieski, Edwards, Kalian, & Carr, 2013).  The number of critically ill patients presenting in the 
ED with sepsis is staggering.  According to Hall et al. (2011), the number of patients in the 
hospital with a principal diagnosis of sepsis or septicemia has more than doubled from 11.6 in 
2000 to 24.0 in 2008 per 10,000 patients with mortality associated with severe sepsis ranging at 
30% - 60% (Hall, Williams, DeFrances, & Golosinskiy, 2011).  Guidelines for early 
identification and treatment of sepsis has been known to decrease sepsis mortality by at least 
14% or 12,500 lives saved per year (Moore, Jones, Kreiner, McKinley, Sucher, Todd, Turner, 
Valdivia, and Moore, 2009).  Evidence based practice has shown that interventions such as the 
sepsis intermediate lactate bundle has proven to be an effective treatment.  This hospital’s 
performance has been well below the target of 55% for intermediate lactate for at least 9 out of 
12 months this past year.  Performance were at times 35 percentage points lower than target.  As 
a result, this medical center is one of the lowest performers in the region when it comes to sepsis 
care.  Therefore, the aim of this project is to increase intermediate lactate bundle compliance by 
12% from 43% to 55% by July 2018.   
 
Goals: 
To provide the best possible patient-centered care maximizing the overall health of our members 
by providing: 
1. Sepsis intermediate lactate bundle education for physicians, nurses, lab and pharmacy 
personnel. 
 
2. Early identification of signs and symptoms of severe sepsis. 
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Family of Measures 
Measure Data Source  Target 
Outcome   
Increased Sepsis Bundle 
compliance for Intermediate 
lactate 
Statit 55% 
Process   
Lactate drawn within 1 hr. of 
ED arrival 
Chart Review - KPHC 95% 
Appropriate antibiotic 
administered within 3 hrs. of 
ED arrival   
Chart Review - KPHC 95% 
Fluids administered 
appropriately within 3 hrs. of 
ED arrival 
Chart Review - KPHC 95% 
Repeat lactate drawn within 6 
hrs. of ED arrival 
Chart Review - KPHC 95% 
Balancing   
Increase in workload for lab 
staff causing delay in 
completing other lab orders 
Chart Review - KPHC  5% 
 
Sponsors  
Chief Nursing Executive Shanthi Margoschis 
Area Quality Leader Jerry Grandon 
 
Team Members  
ED physician champion Dr. Stephanie Zarfoss 
ED nurse champion Tanisha Jimenez/Theresa Garrett 
ED educator Mia Alcavala 
ICU physician champion Dr. Theodore Fong 
ICU nurse champion Quyen Nguyen 
ICU educator Terry Olson 
Laboratory Roniel Duquez 
Radiology Tom Lansburg 
Pharmacy Kelsea Kerr 
Quality nurse (CNL) Jocelyn Alimboyoguen 
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Measurement Strategy 
 
Population Criteria: 
All inpatients with Sepsis diagnosis present on admission and a lactic acid >=2 in ED 
 
Data Collection Method:  
Data will be obtained from retrospective medical record review of patient records for project  
measures per week from January – July 2018.  Data plan will be reevaluated q month based on 
results.  
 
Data Definitions  
Data Element Definition 
Sepsis SIRS plus clinical suspicion of infectious etiology 
SIRS (Systemic Inflammatory Response  
Syndrome) 
Requires 2 of the 5 criteria: 
- Temperature <36 degrees C or >38 degrees C 
- Heart rate >90 beats per minute 
- Respiratory rate >20 breaths per minute or  
  PaCO2 <32 mm Hg 
- WBC <4,000/cubic mm or >12,000/cubic mm or  
  Greater than 10% bands on differential 
- Altered mental status 
Severe Sepsis  Sepsis and any of the following that are 
attributable to infection: 
- Intermediate lactate level (2 to 3.9 mmol/L) 
- Any systolic blood pressure reading below 90 
  mm Hg 
- Any single MAP less than 65 mm HG 
- Systolic blood pressure >40 mm HG below  
  patient baseline 
- Organ dysfunction regardless of lactate level, 
  defined as: hypoxia or mechanical ventilation,  
  delirium, creatinine >20mg/dL, bilirubin > 
  2mg/dl, platelet count <100,000, INR >1.5 or 
  aPTT >60 sec. 
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Measure Description 
Measure Measure Definition Data Collection 
source 
Goal 
Sepsis Intermediate 
Lactate Bundle - % of 
compliance 
N=# cases that met 
each element of the 
bundle 
D=# total number of 
cases that met severe 
sepsis criteria   
Chart audit 100% 
% of patients with 
lactate drawn within 
1 hr. of ED arrival 
N= # patients with 
lactate w/in 1 hr 
D= # patients with 
lactate drawn  
Infoview report 
Chart audit- 
100% 
% patients given 
antibiotics w/in 3 
hours 
N= # patients given 
antibiotics w/in 3 hrs 
D=# patients given 
antibiotics for sepsis  
Infoview report  
Chart audit 
100% 
% patients given 
fluids w/in 3 hours 
N= # patients given 
fluids w/in 3 hrs 
D=# patients given 
fluids for sepsis 
Infoview report  
Chart audit 
100% 
% of patients with 
repeat lactate drawn 
within 6 hrs 
N= # patients with 
lactate w/in 6 hrs 
D= # patients with 
lactate drawn  
Infoview report 
Chart audit- 
100% 
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Driver Diagram 
 
          AIM     PRIMARY      SECONDARY 
      DRIVERS     DRIVERS 
 
 
 
To improve sepsis care by 
increasing compliance 
with the intermediate 
lactate bundle from 43% 
to 55% by July 2018
Relationship-based Care
Communication between 
MD and colleagues
Improve warm hand-off 
between ED and ICU
Improve communication 
between lab and nursing
Care Coordination
Standardized warm  
hand-off
Establish nurse draw vs. 
lab draw
Evidence-based Practice
Standardized lab collection 
processes
Standardized procedure 
nurse draw of repeat lactic 
acid
Educational inservice 
related to sepsis care
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Recommendations for Changes  
1. Develop Sepsis screening tool to help frontline nurses recognize early signs of Sepsis. 
2. Develop a standardized process between lab and nursing for repeat lactate orders. 
3. Develop a system for timely reassessment of patient diagnosed with sepsis. 
 
Project Timeline 
Kotter’s Change 
Model 
Creating a change 
climate Engaging & enabling others 
Implementing & sustaining 
change 
Tasks Week 
1 
Week 
2 
Week 
3 
Week 
4 
Week 
5 
Week 
6 
Week 
7 
Week 
8 
Week 
9 
Week 
10 
Week 
11 
Week 
12 - 24 
On-
going  
Microsystem 
Assessment 
                          
Develop Aim                           
Identify team                           
Sepsis Workgroup 
meetings 
                          
Develop project charter                           
Staff interview                           
Develop training plan                           
Staff Education & 
training  
                          
Observe Sepsis alerts                           
Chart audit for 
compliance with bundle 
                          
Attend staff in-service 
meetings 
                          
Address any 
outstanding issues 
                          
 
Lessons Learned  
1. Identified that there is a sepsis workgroup already in existence but not effective 
2. Identified that there is variation in the approach to sepsis identification and treatment 
3. Gaps in sepsis care specifically around patient reassessment 
4. Lack of warm hand off between departments i.e. lab and nursing, ED staff and ICU staff 
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CNL Competencies 
The CNL as defined by the American College in Nursing is “a master’s educated nurse, 
prepared for practice across the continuum of care within any healthcare setting” 
(“American Association of Colleges of Nursing | Clinical Nurse Leader (CNL),” n.d.).  They 
also implement evidence-based practice in all healthcare settings.  CNLs educate individuals, 
families, groups, and other health care providers.  They lead in clinical decision making, and 
they oversee care delivery and outcomes. (Harris, Roussel, & Thomas, 2014)  
The CNL role is in a unique position to reinforce change, and has been historically proven 
effective in facilitating changes at a microsystem level, having a positive impact on patient 
outcomes (Stanley et al., 2008). As a team leader and a team member, the CNL functions as a 
leader within the microsystem and a quality manager, proficient with interdepartmental, and 
interdisciplinary communication, while being skillful at identifying departmental needs and 
championing cost effective, evidence based care within the microsystem (Wienand, et al., 2015). 
As a member of a profession, bound by the ongoing challenge to effect positive change in health 
care practice and outcomes, the CNL has a large skill set to draw upon (American Association of 
Colleges of Nursing, 2017). As an advocate, the CNL role provides an opportunity to address the 
concerns of colleagues, providing a platform for discussion, providing opportunities to reinforce 
the positives. Additionally, through incorporating the role of an educator where there may be a 
lack of clarity, the CNL can also encourage team members to address their concerns and initiate 
discussion. The CNL’s ability to facilitate working relationships within the microsystem while 
developing a successful implementation of sepsis care interventions in the ICU setting can 
further enhance the care provided to the patient.  Ultimately, our shared agenda is to provide the 
best care possible for our patients. 
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Appendix D 
Intermediate Lactate Bundle Compliance 
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Appendix E 
Repeat Lactate Compliance 
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Appendix F 
Estimated Cost of Business Plan 
Staff Hour/Unit  Hourly Rate  Final Cost  
RN champion salary 4 hrs./wk x 24 wks 
= 96 hours 
$75.00 $7,200 
Lab champion salary 4 hrs./wk x 24 wks 
= 96 hours 
$50.00 $4,800 
Educator champion salary 4 hrs./wk x 24 wks 
= 96 hours 
$75.00 $7,200 
Office Supplies (copy paper, chart 
pads, markers, highlighter, pens)  
  
$800 
Educational Materials (badge cards, 
etc.) 
  
$2,000 
Total Operating Expenses: 
 
$200.00 $22,000 
Projected Savings 
Hard Financial Benefit  12-month impact  Key Assumptions  
Decrease hospital days by average of 
4.7 days 
Jul – Nov 16 average LOS: 
Target not met: 9 days 
Target met:    4.3 days 
52% reduction Approx. $18,000 
per case –
Projecting 
reduction of 4.7 
days per case  
(516 cases/year): 
$4,850,400/year 
Severe Sepsis rates for 
one year will follow 
trend of  
Jul – Nov 16  
Average hospital cost 
of $6,000/day 
Decrease ICU LOS by average of 3.2 
days ($2000 average per day) Jul – 
Nov 16 average LOS: 
Target not met: 6 days 
Target met:    2.8 days 
53% reduction Approx. $6,000 per 
case – Projecting 
reduction of 3 days 
per case  
(516 cases/year): 
$1,651,200/year 
Severe Sepsis rates for 
one year will follow 
trend of  
Jul – Nov 16  
Average hospital cost 
of $2,000/day 
Averted ICU Admissions 10% Approx. 100 cases 
would be averted 
with avg. hospital 
LOS of 5 days: 
$1,000,000/year 
Based on screening 
eligibility for severe 
sepsis care and not 
meeting criteria: 
Average ICU LOS 
$2,000/day over regular 
hospital bed for 5 days 
Total Savings:  $7,501,000  
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Appendix G 
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Appendix H 
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Appendix I 
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Appendix J 
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Appendix K 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cost
•Alert fatigue•Leverging technology to identify septic patients
Inconsistent hand-off between 
nursing and lab
•No standard hand-off 
template 
•Lack of leadership
•Insufficient education/ 
training
•Interruptions during care
•Evidence-based
•Great Teamwork
•Commitment to provide 
quality care
Strengths Weakness
ThreatsOpportunities
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Appendix L 
 
